Incyte (INCY) Cost of Revenue (2012 - 2026)

Incyte (INCY) has 15 years of Cost of Revenue data on file, last reported at $105.0 million in Q2 2026.

• Quarterly Cost of Revenue rose 33.25% year-over-year to $105.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $429.7 million (up 31.62% YoY) and the FY2025 annual result came in at $372.1 million, up 19.25% from the prior year.
• Cost of Revenue was little changed at $105.0 million in Q2 2026, from $104.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $121.2 million in Q4 2025 to a low of $42.6 million in Q1 2022.
• A 5-year average of $75.3 million and a median of $71.5 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 45.84% — and 2025, when it increased 2.78%.
• Tracing INCY's Cost of Revenue over 5 years: stood at $59.2 million in 2022, then grew by 17.9% to $69.8 million in 2023, then gained by 26.86% to $88.5 million in 2024, then jumped by 36.94% to $121.2 million in 2025, then dropped by 13.38% to $105.0 million in 2026.
• The last three Cost of Revenue figures came in at $105.0 million (Q2 2026), $104.5 million (Q1 2026), and $121.2 million (Q4 2025), per Business Quant data.